Connor, Clark & Lunn Investment Management Ltd. DICERNA PHARMACEUTICALS INC Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $20 Billion
  • Q4 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
N/A
-167,538 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
N/A
79,527 Added 90.36%
167,538 $3.38 Million
Q2 2021

Aug 12, 2021
SELL
N/A
-147,873 Reduced 62.69%
88,011 $3.29 Million
Q1 2021

May 13, 2021
SELL
N/A
-64,017 Reduced 21.35%
235,884 $6.03 Million
Q4 2020

Feb 16, 2021
BUY
N/A
1,930 Added 0.65%
299,901 $6.61 Million
Q3 2020

Nov 12, 2020
BUY
N/A
25,585 Added 9.39%
297,971 $5.36 Million
Q2 2020

Aug 13, 2020
SELL
N/A
-22,789 Reduced 7.72%
272,386 $6.92 Million
Q1 2020

May 13, 2020
BUY
N/A
109,325 Added 58.82%
295,175 $0
Q4 2019

Feb 12, 2020
BUY
N/A
185,850 New
185,850 $4.09 Million
Q4 2017

Feb 09, 2018
SELL
N/A
-68,975 Closed
0 $0
Q3 2017

Nov 14, 2017
SELL
N/A
-10,300 Reduced 12.99%
68,975 $397,000
Q2 2017

Aug 14, 2017
BUY
N/A
79,275
79,275 $251,000
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email